Log in

OTCMKTS:VBIO - Vitality Biopharma Stock Price, Forecast & News

$0.07
+0.01 (+16.67 %)
(As of 12/6/2019 04:00 PM ET)
Today's Range
$0.06
Now: $0.07
$0.07
50-Day Range
$0.05
MA: $0.10
$0.15
52-Week Range
$0.01
Now: $0.07
$1.15
Volume13,232 shs
Average Volume19,747 shs
Market Capitalization$3.43 million
P/E RatioN/A
Dividend YieldN/A
Beta1.85
Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of neurological and inflammatory disorders in the United States. The company's products in pipeline include VBX-100, an oral cannabinoid formulation for inflammatory bowel disease, C.difficile-associated diarrhea and colitis, and narcotic bowel syndrome; and VBX-210, a cannabinoid formulation, which is in preclinical studies for the treatment of gastrointestinal conditions. It develops additional cannabinoid product formulations for refractory pain and autism spectrum disorder. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. The company was founded in 2007 and is based in Los Angeles, California.

Industry, Sector and Symbol

Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:VBIO
Previous SymbolOTCMKTS:STVF
CUSIPN/A
Phone530-231-7800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$260,000.00
Book Value$0.10 per share

Profitability

Net Income$-13,120,000.00
Net Margins-7,774.90%

Miscellaneous

Employees7
Market Cap$3.43 million
Next Earnings Date2/13/2020 (Estimated)
OptionableNot Optionable

Receive VBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for VBIO and its competitors with MarketBeat's FREE daily newsletter.


Vitality Biopharma (OTCMKTS:VBIO) Frequently Asked Questions

What is Vitality Biopharma's stock symbol?

Vitality Biopharma trades on the OTCMKTS under the ticker symbol "VBIO."

When is Vitality Biopharma's next earnings date?

Vitality Biopharma is scheduled to release their next quarterly earnings announcement on Thursday, February 13th 2020. View Earnings Estimates for Vitality Biopharma.

Has Vitality Biopharma been receiving favorable news coverage?

News coverage about VBIO stock has been trending negative recently, according to InfoTrie. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Vitality Biopharma earned a media sentiment score of -2.6 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for Vitality Biopharma.

Who are some of Vitality Biopharma's key competitors?

What other stocks do shareholders of Vitality Biopharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vitality Biopharma investors own include Canopy Growth (CGC), Athersys (ATHX), Aurora Cannabis (ACB), Cronos Group (CRON), Aurora Cannabis (ACBFF), OrganiGram (OGI), KushCo (KSHB), OrganiGram (OGI), NVIDIA (NVDA) and CV Sciences (CVSI).

Who are Vitality Biopharma's key executives?

Vitality Biopharma's management team includes the folowing people:
  • Mr. Robert T. Brooke, CEO, Sec., Treasurer, Director & Co-Founder (Age 39)
  • Dr. Brandon J. Zipp Ph.D., Scientific Co-Founder and Director of R&D
  • Dr. J. Jeremiah Mann, VP of Operations & Sr. Agronomist
  • Mr. Richard McKilligan, Controller & Counsel (Age 55)
  • Dr. Dong Yuejin, Partner

How do I buy shares of Vitality Biopharma?

Shares of VBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Vitality Biopharma's stock price today?

One share of VBIO stock can currently be purchased for approximately $0.07.

How big of a company is Vitality Biopharma?

Vitality Biopharma has a market capitalization of $3.43 million and generates $260,000.00 in revenue each year. Vitality Biopharma employs 7 workers across the globe.View Additional Information About Vitality Biopharma.

What is Vitality Biopharma's official website?

The official website for Vitality Biopharma is http://www.vitality.bio/.

How can I contact Vitality Biopharma?

Vitality Biopharma's mailing address is 1901 AVENUE OF THE STARS 2ND FLOOR, LOS ANGELES CA, 90067. The company can be reached via phone at 530-231-7800 or via email at [email protected]


MarketBeat Community Rating for Vitality Biopharma (OTCMKTS VBIO)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  221 (Vote Outperform)
Underperform Votes:  197 (Vote Underperform)
Total Votes:  418
MarketBeat's community ratings are surveys of what our community members think about Vitality Biopharma and other stocks. Vote "Outperform" if you believe VBIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VBIO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/7/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel